These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33811848)

  • 1. Attenuation of lipid levels in triton induced hyperlipidemia rats through rosuvastatin calcium nanoparticles: Pharmacokinetic and pharmacodynamic studies.
    Dudhipala NR; Ettireddy SR; Puchakayala GR
    Chem Phys Lipids; 2021 Jul; 237():105081. PubMed ID: 33811848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
    Rizwanullah M; Amin S; Ahmad J
    J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study.
    Gabr MM; Mortada SM; Sallam MA
    J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
    Dudhipala N; Veerabrahma K
    Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chylomicron mimicking nanocolloidal carriers of rosuvastatin calcium for lymphatic drug targeting and management of hyperlipidemia.
    Beg S; Alam MN; Ahmad FJ; Singh B
    Colloids Surf B Biointerfaces; 2019 May; 177():541-549. PubMed ID: 30825846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated solid lipid nanoparticles.
    Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Erol K; Demirel M
    Int J Pharm; 2020 Mar; 578():119106. PubMed ID: 32014599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery.
    Suares D; Prabhakar B
    Drug Dev Ind Pharm; 2017 Feb; 43(2):213-224. PubMed ID: 27593545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles.
    Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Vural İ; Demirel M
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1635-1645. PubMed ID: 31342792
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancing Solubility and Bioavailability of Rosuvastatin into Self Nanoemulsifying Drug Delivery System.
    Karasulu HY; Gundogdu E; Turk UO; Turgay T; Apaydin S; Simsir IY; Yilmaz C; Karasulu E
    Curr Drug Deliv; 2018; 15(7):1072-1082. PubMed ID: 29484996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Optimized Surfactant-Based PEG-PLCL In Situ Gel Formulation For Enhanced Activity Of Rosuvastatin In Poloxamer-Induced Hyperlipidemic Rats.
    Ahmed TA; Mussari MA; Abdel-Hady SE; El-Say KM
    Drug Des Devel Ther; 2019; 13():4035-4051. PubMed ID: 31839704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid super saturated self-nanoemulsifying drug delivery system (sat-SNEDDS) as a promising alternative to conventional SNEDDS for improvement rosuvastatin calcium oral bioavailability.
    Abo Enin HA; Abdel-Bar HM
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1513-1521. PubMed ID: 27564321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability.
    Gabr MM; Mortada SM; Sallam MA
    Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of nanocochelate by using phosphatidylcholine as lipid carrier for enhancement of permeability and bioavailability of rosuvastatin.
    Pawar AY; Patil SS; More PS; Jadhav PR; Bhavar SR
    Drug Dev Ind Pharm; 2021 Dec; 47(12):2004-2012. PubMed ID: 35658764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Pharmacokinetic Activity of Zotepine via Nanostructured Lipid Carrier System in Wistar Rats for Oral Application.
    Tirumalesh C; Suram D; Dudhipala N; Banala N
    Pharm Nanotechnol; 2020; 8(2):148-160. PubMed ID: 32096755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
    Dudhipala N; Ay AA
    Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.